Skip to main content

BioNTech says it plans to develop an mRNA vaccine to prevent malaria

BioNTech said it plans to develop a highly effective mRNA-based vaccine to prevent malaria, a life-threatening disease that impacts millions of people worldwide each year.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.